{"paper_id":"0383359b-ee23-4cf1-98f4-97286bb9cd77","body_text":"Please use this identifier to cite or link to this item:\nhttp://hdl.handle.net/10397/76863\n| Title: | Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) for use in the treatment of endometriosis | Authors: | Chan, TH Wang, CC |\nIssue Date: | 25-Jul-2017 | Source: | US Patent 9,713,603 B2. Washington, DC: US Patent and Trademark Office, 2017. | Abstract: | Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(-)-EGCG]. Use of Pro-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications. | Rights: | Assignee: The Hong Kong Polytechnic University Assignee: The Chinese University of Hong Kong |\n| Appears in Collections: | Patent |\nFiles in This Item:\n| File | Description | Size | Format | |\n|---|---|---|---|---|\n| us9713603b2.pdf | 1.55 MB | Adobe PDF | View/Open |\nPage views\n141\nLast Week\n2\n2\nLast month\nCitations as of Apr 12, 2026\nDownloads\n124\nCitations as of Apr 12, 2026\nGoogle ScholarTM\nCheck\nItems in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.","source_license":"CC0","license_restricted":false}